Study to Evaluate the Benefit of RUCONEST in Improving Neurological Symptoms in Post COVID-19 Infection
Clinical trial NCT04705831 · COMPLETED
Trial details
- NCT number
- NCT04705831
- Sponsor
- IMMUNOe Research Centers
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-01-11
- Primary completion
- 2024-03-30
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.